Nexalin Technology (NXL) Times Interest Earned (2021 - 2026)
Nexalin Technology's (NXL) quarterly Times Interest Earned came in at -$81.53 in Q1 2026, up 43.24% year-on-year from -$56.92 in Q1 2025, and down 300.16% quarter-over-quarter from $40.74 in Q4 2025.
Nexalin Technology (NXL) Times Interest Earned (2021 - 2026) Analysis & Trends
Nexalin Technology's Times Interest Earned history runs 6 years deep, the most recent figure standing at -$81.53 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 43.24% year-over-year to -$81.53 in Q1 2026; TTM through Mar 2026 was -$2230.9, a 918.32% decrease from a year earlier, with the FY2025 full-year figure at -$99.89, down 6831.2% from the prior year.
- Times Interest Earned declined to -$81.53 in Q1 2026 per NXL's latest filing, from $40.74 in the prior quarter.
- Across five years, Times Interest Earned topped out at $1577.3 in Q4 2024 and bottomed at -$179.18 in Q3 2024.
- The 5-year median for Times Interest Earned is -$82.04 (2023), against an average of $15.06.
- Across the five-year window, Times Interest Earned sank 537.86% in 2023 and soared 1959.38% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$16.21 in 2022, then plunged by 423.18% to -$84.83 in 2023, then surged by 1959.38% to $1577.3 in 2024, then slumped by 97.42% to $40.74 in 2025, then tumbled by 300.16% to -$81.53 in 2026.
- Per Business Quant, the three latest NXL Times Interest Earned figures stand at -$81.53 (Q1 2026), $40.74 (Q4 2025), and -$101.98 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | -81.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -81.53 |
| Dec 31, 2025 | 40.74 |
| Sep 30, 2025 | -101.98 |
| Jun 30, 2025 | -115.36 |
| Mar 31, 2025 | -143.66 |
| Dec 31, 2024 | 1,577.29 |
| Sep 30, 2024 | -179.18 |
| Jun 30, 2024 | -96.08 |
| Mar 31, 2024 | -79.53 |
| Dec 31, 2023 | -84.83 |
| Sep 30, 2023 | -178.93 |
| Jun 30, 2023 | -64.95 |
| Mar 31, 2023 | -82.04 |
| Dec 31, 2022 | -16.21 |
| Sep 30, 2022 | -28.05 |
| Jun 30, 2022 | -89.02 |
| Mar 31, 2022 | -20.69 |
| Dec 31, 2021 | 9.49 |
| Sep 30, 2021 | -66.07 |